{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T02:54:29Z","timestamp":1788836069050,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002456","name":"Chonnam National University","doi-asserted-by":"publisher","award":["2021-2455"],"award-info":[{"award-number":["2021-2455"]}],"id":[{"id":"10.13039\/501100002456","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002456","name":"Chonnam National University","doi-asserted-by":"publisher","award":["CNUH-2021-378"],"award-info":[{"award-number":["CNUH-2021-378"]}],"id":[{"id":"10.13039\/501100002456","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2019R1I1A3A01058853"],"award-info":[{"award-number":["2019R1I1A3A01058853"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jgar.2021.12.005","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T12:29:44Z","timestamp":1639484984000},"page":"43-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Rifamycin resistance, rpoB gene mutation and clinical outcomes of Staphylococcus species isolates from prosthetic joint infections in Republic of Korea"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0648-2226","authenticated-orcid":false,"given":"Yunjung","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Sung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Mi","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan-Joong","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Hoon","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0162-6155","authenticated-orcid":false,"given":"Seong Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uh Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Ji","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1577-678X","authenticated-orcid":false,"given":"Sook-In","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2836-6963","authenticated-orcid":false,"given":"Kyung-Hwa","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2021.12.005_bib0001","doi-asserted-by":"crossref","first-page":"850","DOI":"10.5588\/ijtld.18.0658","article-title":"Multidrug-resistant tuberculosis in South Korea: a retrospective analysis of national registry data in 2011\u20132015","volume":"23","author":"Lee","year":"2019","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jgar.2021.12.005_bib0002","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1128\/CMR.00034-09","article-title":"Rifampin combination therapy for nonmycobacterial infections","volume":"23","author":"Forrest","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jgar.2021.12.005_bib0003","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/infdis\/125.5.486","article-title":"Killing of intraleukocytic Staphylococcus aureus by rifampin: in-vitro and in-vivo studies","volume":"125","author":"Mandell","year":"1972","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jgar.2021.12.005_bib0004","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJMcp0905029","article-title":"Clinical practice. Infection associated with prosthetic joints","volume":"361","author":"Del Pozo","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgar.2021.12.005_bib0005","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/AAC.50.1.298-309.2006","article-title":"Molecular genetic and structural modeling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampin resistance genotypes in relation to clinical prevalence","volume":"50","author":"O'Neill","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2021.12.005_bib0006","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.ijantimicag.2017.12.019","article-title":"Rifampicin resistance in Staphylococcus epidermidis: molecular characterisation and fitness cost of rpoB mutations","volume":"51","author":"Wi","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2021.12.005_bib0007","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/jac\/dkaa061","article-title":"Antibiofilm and intraosteoblastic activities of rifamycins against Staphylococcus aureus: promising in vitro profile of rifabutin","volume":"75","author":"Abad","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2021.12.005_bib0008","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.tim.2008.09.008","article-title":"The rpoB gene as a tool for clinical microbiologists","volume":"17","author":"Adekambi","year":"2009","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.jgar.2021.12.005_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2020.115173","article-title":"Antimicrobial susceptibility of Staphylococcus species isolated from prosthetic joints with a focus on fluoroquinolone-resistance mechanisms","volume":"99","author":"Darboe","year":"2021","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2021.12.005_bib0010","doi-asserted-by":"crossref","DOI":"10.1177\/03000605211002784","article-title":"Trends in microbiological profiles and antibiotic resistance in periprosthetic joint infections","volume":"49","author":"Hu","year":"2021","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jgar.2021.12.005_bib0011","series-title":"Performance standards for antimicrobial susceptibility testing","year":"2019"},{"key":"10.1016\/j.jgar.2021.12.005_bib0012","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.diagmicrobio.2016.01.008","article-title":"In vitro activity of tedizolid against staphylococci isolated from prosthetic joint infections","volume":"85","author":"Schmidt-Malan","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2021.12.005_bib0013","series-title":"Performance standards for antimicrobial susceptibility testing","year":"2015"},{"key":"10.1016\/j.jgar.2021.12.005_bib0014","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","year":"2015"},{"key":"10.1016\/j.jgar.2021.12.005_bib0015","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1128\/AAC.42.10.2590","article-title":"Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus","volume":"42","author":"Aubry-Damon","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2021.12.005_bib0016","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/cid\/cir402","article-title":"Outcome and predictors of treatment failure in total hip\/knee prosthetic joint infections due to Staphylococcus aureus","volume":"53","author":"Senneville","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2021.12.005_bib0017","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s15010-012-0325-7","article-title":"Factors associated with rifampin resistance in staphylococcal periprosthetic joint infections (PJI): a matched case\u2013control study","volume":"41","author":"Achermann","year":"2013","journal-title":"Infection"},{"key":"10.1016\/j.jgar.2021.12.005_bib0018","doi-asserted-by":"crossref","first-page":"e00959","DOI":"10.1128\/AAC.00959-19","article-title":"In vitro activity of rifampin, rifabutin, rifapentine, and rifaximin against planktonic and biofilm states of staphylococci isolated from periprosthetic joint infection","volume":"63","author":"Albano","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2021.12.005_bib0019","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/jac\/dkr059","article-title":"Epidemiological and molecular aspects of rifampicin-resistant Staphylococcus aureus isolated from wounds, blood and respiratory samples","volume":"66","author":"Villar","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2021.12.005_bib0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1471-2180-10-68","article-title":"Molecular characterization of resistance to rifampicin in an emerging hospital-associated methicillin-resistant Staphylococcus aureus clone ST228","volume":"10","author":"Mick","year":"2010","journal-title":"Spain. BMC Microbiol"},{"key":"10.1016\/j.jgar.2021.12.005_bib0021","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1086\/430377","article-title":"Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997\u20132000","volume":"41","author":"Li","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2021.12.005_bib0022","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1128\/AAC.43.11.2813","article-title":"Molecular characterization of rpoB mutations conferring cross-resistance to rifamycins on methicillin-resistant Staphylococcus aureus","volume":"43","author":"Wichelhaus","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2021.12.005_bib0023","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/jac\/39.6.817","article-title":"Factors affecting development of rifampicin resistance in biofilm-producing Staphylococcus epidermidis","volume":"39","author":"Svensson","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2021.12.005_bib0024","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/cid\/ciab426","article-title":"If, when, and how to use rifampin in acute staphylococcal periprosthetic joint infections, a multicentre observational study","volume":"73","author":"Beldman","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2021.12.005_bib0025","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmi.2016.10.002","article-title":"The use of rifampin in staphylococcal orthopaedic-device-related infections","volume":"23","author":"Sendi","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2021.12.005_bib0026","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1128\/AAC.00300-08","article-title":"Addition of rifampin to standard therapy for treatment of native valve infective endocarditis caused by Staphylococcus aureus","volume":"52","author":"Riedel","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2021.12.005_bib0027","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJMoa1710926","article-title":"Oral versus intravenous antibiotics for bone and joint infection","volume":"380","author":"Li","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgar.2021.12.005_bib0028","series-title":"Breakpoint tables for interpretation of MICs and zone diameters","year":"2021"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716521002769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716521002769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:23:07Z","timestamp":1778858587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716521002769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":28,"alternative-id":["S2213716521002769"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2021.12.005","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rifamycin resistance, rpoB gene mutation and clinical outcomes of Staphylococcus species isolates from prosthetic joint infections in Republic of Korea","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2021.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}